Lantheus Holdings
(NASDAQ:LNTH)
$60.89
At close: Nov 28(Delayed 15-Minutes)
Get Real Time Here
$60.89
PreMarket: 4:01PM EDT
Day Range- - -52 Wk Range23.51 - 87.47Open / Close- / -Float / Outstanding57.3M / 68.8M
Vol / Avg.- / 1.3MMkt Cap4.2BP/E41.1450d Avg. Price66.98
Div / Yield-Payout Ratio-Total Float57.3MEPS0.89

Lantheus Holdings Stock (NASDAQ:LNTH), Quotes and News Summary

Lantheus Holdings Stock (NASDAQ: LNTH) stock price, news, charts, stock research, profile.

Loading...
Day Range- - -52 Wk Range23.51 - 87.47Open / Close- / -Float / Outstanding57.3M / 68.8M
Vol / Avg.- / 1.3MMkt Cap4.2BP/E41.1450d Avg. Price66.98
Div / Yield-Payout Ratio-Total Float57.3MEPS0.89
Globe Newswire - Nov 3, 2022, 7:00AM
Globe Newswire - Aug 4, 2022, 7:00AM
Globe Newswire - May 16, 2022, 4:30PM
Globe Newswire - Mar 3, 2022, 4:30PM
InvestorPlace - Nov 18, 2022, 2:16PM
Seeking Alpha - Nov 2, 2022, 12:28PM
InvestorPlace - Sep 26, 2022, 6:45AM
InvestorsObserver - Sep 23, 2022, 12:22PM
Seeking Alpha - Sep 14, 2022, 1:16PM
InvestorPlace - Sep 1, 2022, 2:57PM
Sector: Health Care.Industry: Health Care Equipment & Supplies
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its imaging products and agents assist clinicians in the diagnosis and treatment of cardiovascular and other diseases. Its agents are typically non-radioactive compounds that are used in diagnostic procedures, such as cardiac ultrasounds, or echocardiograms, x-ray imaging used by physicians to progress the clarity of the diagnostic image. Its portfolio of imaging products includes medical radiopharmaceuticals such as DEFINITY, TechneLite, Xenon Xe 133 Gas, Cardiolite, and Neurolite. Its revenue is generated from the sales of diagnostic imaging agents to wholesalers, distributors radiopharmacy and directly to hospitals and clinics predominantly in the United States.

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-02-23
REV
Q3 2022Est.ActualSurprise
EPS0.8300.990 0.1600
REV228.060M239.292M11.232M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Lantheus Holdings (LNTH) stock?

A

You can purchase shares of Lantheus Holdings (NASDAQ: LNTH) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Lantheus Holdings's (LNTH) competitors?

Q

What is the target price for Lantheus Holdings (LNTH) stock?

A

The latest price target for Lantheus Holdings (NASDAQ: LNTH) was reported by SVB Leerink on Tuesday, November 15, 2022. The analyst firm set a price target for 120.00 expecting LNTH to rise to within 12 months (a possible 97.08% upside). 8 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Lantheus Holdings (LNTH)?

A

The stock price for Lantheus Holdings (NASDAQ: LNTH) is $60.89 last updated November 28, 2022, 9:00 PM UTC.

Q

Does Lantheus Holdings (LNTH) pay a dividend?

A

There are no upcoming dividends for Lantheus Holdings.

Q

When is Lantheus Holdings (NASDAQ:LNTH) reporting earnings?

A

Lantheus Holdings’s Q4 earnings are confirmed for Thursday, February 23, 2023.

Q

Is Lantheus Holdings (LNTH) going to split?

A

There is no upcoming split for Lantheus Holdings.

Q

What sector and industry does Lantheus Holdings (LNTH) operate in?

A

Lantheus Holdings is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.